May 14, 2018 / 12:07 PM / 9 days ago

BRIEF-Emblem And Canntab Receive Health Canada Approval For R&D Of Cannabinoid-Based Oral Sustained Release Formulation

May 14 (Reuters) - Emblem Corp:

* EMBLEM AND CANNTAB THERAPEUTICS ANNOUNCE HEALTH CANADA APPROVAL FOR RESEARCH AND DEVELOPMENT OF CANNABINOID-BASED ORAL SUSTAINED RELEASE FORMULATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below